FDA Approves BCMA-Targeted CAR T-Cell Therapy for Multiple Myeloma
Cancer Currents: An NCI Cancer Research Blog,
The Food and Drug Administration has approved idecabtagene vicleucel (Abecma) for some people with multiple myeloma. The…
CAR T cell therapy for multiple myeloma: where are we now and where are we headed?
Overview of attention for article published in Leukemia & Lymphoma, November 2017
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Among the highest-scoring outputs from this source (#47 of 4,806)
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
High Attention Score compared to outputs of the same age and source (96th percentile)
Readers on
- mendeley
- 113 Mendeley